4 questions with immunology researcher Susan Bullman
Susan Bullman, Ph.D., has studied bacteria and how it contributes to cancer for decades. Her research led her from her home in Ireland and eventually to MD Anderson and the James P. Allison Institute, where she serves as an associate member.
We asked Bullman four questions about her research and her career. Here’s what she had to say.
How did you get your start as a cancer researcher?During my graduate studies in Ireland...

4 questions for mathematical oncologist Heiko Enderling, Ph.D.
For Heiko Enderling, Ph.D., the start of a question to solve a problem often begins with a pen on a paper napkin or chalk on a chalkboard....
Committed to making cervical cancer screening easier
When it comes to eliminating cervical cancer, prevention and screening are vital. Behavioral science and cancer researcher Jane Montealegre...
11 new research advances from the past year
Over the past year, MD Anderson researchers and clinicians have investigated the gut microbiome, examined the earliest genesis of lung adenocarcinoma cells, tested new and improved therapies, and more. Their breakthroughs in cancer research continue to drive forward our mission to end cancer.
Here are 11 novel MD Anderson research highlights from last year.
1. Eating beans improves gut health, regulates immune and inflammatory...
Finding hope for cancer patients in ferroptosis research
Guang Lei, M.D., Ph.D., spends his days in a lab studying ferroptosis, a type of programmed cell death.
But it’s not a love of science...
Advances in small cell lung cancer classification
Most patients with lung cancer have non-small cell lung cancer. However, around 15% of patients have a less-common type called small cell...
Exploring pancreatic cancer vaccines: What’s next?
When most people think of a vaccine, they think of the prevention of a disease. For pancreatic cancer vaccines, though, it’s a little bit...
What is the future of cell therapy in cancer treatment?
Cell therapies, often described as ‘living therapies,’ are a form of immunotherapy created using immune cells from a patient or healthy donor...
How beautiful images can advance immunotherapy
They say a picture is worth 1,000 words.
In the case of MD Anderson’s immunotherapy platform, part of the James P. Allison Institute...
Bugs as drugs: What is microbial cell therapy?
When it comes to cancer therapies, the use of bacteria may sound unusual, but it’s a rapidly developing field with exciting potential....